| ISIN | CH0011553598 |
|---|---|
| Valor Number | 1155359 |
| Bloomberg Global ID | BBG000GH31H0 |
| Fund Name | GENERALI Equity Fund Switzerland A |
| Fund Provider |
Generali Investments Schweiz AG
Soodmattenstrasse 2 8134 Adliswil 1 E-Mail: headoffice.ch@generali-invest.com Web: www.generali.ch/investments |
| Fund Provider | Generali Investments Schweiz AG |
| Representative in Switzerland | |
| Distributor(s) |
Generali Holding AG Adliswil Phone: +41 58 472 44 44 |
| Asset Class | Equities |
| EFC Category | |
| Distribution Policy | Accumulation |
| Home Country | Switzerland |
| Issuing Condition | The fund management company and/or distributor charges an issuing commission (different commissions can be charged for the same fund depending on the sales channel) |
| Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
| Investment Strategy *** | N/A |
| Peculiarities |
| Current Price * | 424.88 CHF | 23.10.2025 |
|---|---|---|
| Previous Price * | 425.40 CHF | 22.10.2025 |
| 52 Week High * | 432.01 CHF | 03.03.2025 |
| 52 Week Low * | 363.00 CHF | 09.04.2025 |
| NAV * | 424.88 CHF | 23.10.2025 |
| Issue Price * | ||
| Redemption Price * | ||
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 54,726,984 | |
| Unit/Share Assets *** | 54,679,185 | |
| Trading Information SIX | ||
| YTD Performance | +10.14% |
30.12.2024 - 23.10.2025
30.12.2024 23.10.2025 |
|---|---|---|
| 1 month | +2.85% |
23.09.2025 - 23.10.2025
23.09.2025 23.10.2025 |
| 3 months | +2.24% |
23.07.2025 - 23.10.2025
23.07.2025 23.10.2025 |
| 6 months | +6.84% |
23.04.2025 - 23.10.2025
23.04.2025 23.10.2025 |
| 1 year | +5.94% |
23.10.2024 - 23.10.2025
23.10.2024 23.10.2025 |
| 2 years | +24.02% |
23.10.2023 - 23.10.2025
23.10.2023 23.10.2025 |
| 3 years | +22.02% |
24.10.2022 - 23.10.2025
24.10.2022 23.10.2025 |
| 5 years | +31.83% |
23.10.2020 - 23.10.2025
23.10.2020 23.10.2025 |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Novartis AG Registered Shares | 12.81% | |
|---|---|---|
| Roche Holding AG | 11.64% | |
| Nestle SA | 11.48% | |
| UBS Group AG Registered Shares | 6.33% | |
| Zurich Insurance Group AG | 5.28% | |
| Compagnie Financiere Richemont SA Class A | 4.43% | |
| ABB Ltd | 4.19% | |
| Swiss Re AG | 3.28% | |
| Lonza Group Ltd | 2.89% | |
| Alcon Inc | 2.71% | |
| Last data update | 30.09.2025 | |
| TER | 1.00% |
|---|---|
| TER date | 31.03.2025 |
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | 1.50% |
| Ongoing Charges *** | |
|
SRRI ***
|
|
| SRRI date *** | 30.09.2025 |